Current Perspectives on Massive Transfusion in Trauma Patients

Please note: AABB reserves the right to make updates to this program.

Live Program Date: Wednesday, June 8, 2016 – On-Demand Version Available
Master Program # 164910 (see program format numbers below under Registration)

Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Physicians, Technologists, Nurses, Managers/Supervisors, Perfusionists
Teaching Level: Intermediate

Director/Moderator: Jan Stuckey MS, MT(ASCP)BB
Speaker: Timothy H. Pohlman, MD, FACS

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Define scope of Massive Transfusion as it relates to Adult or Pediatric Trauma cases.
  • Provide the rationale for selection and quantity of blood components required in Trauma Cases (e.g. 1:1:1; 1:2:1; 3:2:1, etc.).
  • Review cases of massive transfusion complications.
  • Describe hemostatic abnormalities in massive transfusion and possible corrective actions (focusing on microvascular damage).
  • Discuss use of adjunct therapies in massive transfusion (e.g. recombinant factors, DAVVP, antifibrinolytics, liquid plasma).

Program Description

Through the use of case studies, this session will review the progress and variability in treatment of trauma cases within the United States. Focus to be applied to methods and availability of trauma care, complications of delayed or hampered treatments as well as alternatives to the use of traditional blood component therapies.


   Program #
Single Viewer: On-Demand Register164910R
Group Viewing: On-Demand Register164910R-GRP